Date | Time | Source | Headline | Symbol | Company |
01/04/2008 | 5:35PM | PR Newswire (US) | QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
01/03/2008 | 2:58PM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
12/31/2007 | 9:11AM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
12/31/2007 | 8:00AM | Business Wire | Pfizer Inc Announces Completion of the Tender Offer Relating to Outstanding Shares of Coley Pharmaceutical Group, Inc. | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
12/21/2007 | 4:13PM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Statement of Beneficial Ownership (SC 13D) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
12/18/2007 | 8:32AM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
12/18/2007 | 8:00AM | Business Wire | Pfizer Inc Clears Antitrust Review for Acquisition of All Outstanding Shares of Coley Pharmaceutical Group, Inc. | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
12/14/2007 | 4:12PM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
11/30/2007 | 8:59AM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
11/30/2007 | 8:55AM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Tender offer statement by Third Party (SC TO-T) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
11/28/2007 | 6:04AM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
11/26/2007 | 1:29PM | PR Newswire (US) | Coley Pharmaceutical Group to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
11/20/2007 | 4:50PM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended Current report filing (8-K/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
11/19/2007 | 12:58PM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended Statement of Ownership (SC 13G/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
11/16/2007 | 4:15PM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Current report filing (8-K) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
11/16/2007 | 2:30PM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
11/16/2007 | 10:54AM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
11/16/2007 | 9:35AM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
11/01/2007 | 4:05PM | PR Newswire (US) | Coley Pharmaceutical Group Reports Third Quarter and Nine-month Financial Results | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
10/31/2007 | 2:24PM | PR Newswire (US) | Coley Pharmaceutical Group to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
10/30/2007 | 9:00AM | PR Newswire (US) | Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
10/29/2007 | 9:00AM | PR Newswire (US) | Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythemat | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
10/26/2007 | 11:34AM | PR Newswire (US) | Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
10/25/2007 | 8:30AM | PR Newswire (US) | Coley Pharmaceutical Group to Report Third Quarter Results on November 1, 2007 | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
10/09/2007 | 8:11AM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Securities Registration (section 12(b)) (8-A12B) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
10/09/2007 | 8:09AM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Current report filing (8-K) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
10/08/2007 | 8:30AM | PR Newswire (US) | Coley Pharmaceutical Group Adopts Shareholder Rights Plan | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
09/20/2007 | 3:18PM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. (Other) (4) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
09/20/2007 | 3:18PM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. (Other) (4) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
09/20/2007 | 3:17PM | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. (Other) (4) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |